Logo image of EVMT.CA

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Fundamental Analysis

TSX-V:EVMT - TSX Venture Exchange - CA30053H1055 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

2

EVMT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of EVMT have multiple concerns. EVMT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EVMT had negative earnings in the past year.
EVMT had a positive operating cash flow in the past year.
In the past 5 years EVMT always reported negative net income.
EVMT had negative operating cash flow in 4 of the past 5 years.
EVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFEVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of EVMT (-66.99%) is better than 68.75% of its industry peers.
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROIC N/A
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
EVMT.CA Yearly ROA, ROE, ROICEVMT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

EVMT has a worse Gross Margin (33.80%) than 62.50% of its industry peers.
EVMT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EVMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
EVMT.CA Yearly Profit, Operating, Gross MarginsEVMT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

EVMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EVMT has been increased compared to 1 year ago.
EVMT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EVMT has a worse debt to assets ratio.
EVMT.CA Yearly Shares OutstandingEVMT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
EVMT.CA Yearly Total Debt VS Total AssetsEVMT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -2.59, we must say that EVMT is in the distress zone and has some risk of bankruptcy.
EVMT's Altman-Z score of -2.59 is fine compared to the rest of the industry. EVMT outperforms 62.50% of its industry peers.
The Debt to FCF ratio of EVMT is 3.25, which is a good value as it means it would take EVMT, 3.25 years of fcf income to pay off all of its debts.
EVMT's Debt to FCF ratio of 3.25 is amongst the best of the industry. EVMT outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Altman-Z -2.59
ROIC/WACCN/A
WACC8.49%
EVMT.CA Yearly LT Debt VS Equity VS FCFEVMT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

EVMT has a Current Ratio of 0.51. This is a bad value and indicates that EVMT is not financially healthy enough and could expect problems in meeting its short term obligations.
EVMT has a Current ratio of 0.51. This is in the lower half of the industry: EVMT underperforms 62.50% of its industry peers.
EVMT has a Quick Ratio of 0.51. This is a bad value and indicates that EVMT is not financially healthy enough and could expect problems in meeting its short term obligations.
EVMT has a Quick ratio of 0.24. This is in the lower half of the industry: EVMT underperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
EVMT.CA Yearly Current Assets VS Current LiabilitesEVMT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.50% over the past year.
The Revenue for EVMT has decreased by -39.95% in the past year. This is quite bad
Measured over the past years, EVMT shows a very strong growth in Revenue. The Revenue has been growing by 73.88% on average per year.
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVMT.CA Yearly Revenue VS EstimatesEVMT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EVMT.CA Yearly EPS VS EstimatesEVMT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVMT. In the last year negative earnings were reported.
Also next year EVMT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVMT.CA Price Earnings VS Forward Price EarningsEVMT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EVMT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
EVMT.CA Per share dataEVMT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVOME MEDICAL TECHNOLOGIES I

TSX-V:EVMT (5/6/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-11 2025-08-11
Inst Owners9.89%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap300.85K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.09
FCFY1784.34%
OCF(TTM)0.09
OCFY1796.34%
SpS0.8
BVpS-0.06
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.8%
FCFM 11.1%
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
F-Score3
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Debt/EBITDA N/A
Cap/Depr 1.09%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -2.59
F-Score3
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y434.86%
OCF growth 3YN/A
OCF growth 5YN/A